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Comparison of the allele frequencies of the MIF microsatellite
Controls THR
Women Men Women Men
Allele Count Freq Count Freq Count Freq Count Freq
5 1402 25.4 1439 25.3 671 23.1 474 24.3
6 3453 62.5 3574 62.7 1853 63.7 1237 63.5
7 669 12.1 685 12.0 386 13.3 237 12.2
Total 5524 5698 2910 1948
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A197IX (COL9A1), IL1B, and matrix metalloproteinase-13 (MMP13) gene
expression were measured using SYBR Green-based qRT-PCR and were
correlated with methylation status analysed by pyrosequencing
methodology.
Results: Hypoxia resulted in a >50-fold and >10-fold increase in rela-
tive expression of COL9A1 and IL1B respectively. This was inversely
correlated to the DNA methylation status of these genes. Expression of
MMP13 was reduced at 2% oxygen tension in control cells. Relative
expression of MMP13 increased in cells stimulated with IL-1b and 5-
aza-dC in normoxic conditions, and this effect was eliminated at low
oxygen tension although no correlation with methylation status was
observed.
Conclusions: These ﬁndings demonstrate a role for hypoxia in the
regulation anabolic and catabolic gene expression and the inﬂuence of
changes in DNA methylation. These results further support the role of
epigenetics in OA and critically, highlight the complex relationship
between the physiological environment of cartilaginous cells and the
osteoarthritic process with implications for therapeutic intervention
and our understanding of OA pathophysiology.
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VALIDATION OF THE ASSOCIATION OF A FUNCTIONAL
MICROSATELLITE IN MACROPHAGE MIGRATION FACTOR WITH HIP
OA
A. Gonzalez, L. Vidal, M. Calaza. Hosp. Clinico Univ.rio de Santiago,
Santiago de Compostela, Spain
Purpose: Microsatellites are not amenable for high-throughput geno-
typing and have been excluded from GWAS. However, several micro-
satellites have been found to affect expression of nearby genes and a
couple of them, in the asporin and BMP5 genes, have been associated
with susceptibility to OA in multiple studies. In a recent exploration of
functional microsatellites we found association of the -794 CATT
microsatellite in the MIF gene with hip OA in 1782 patients compared
with 1878 healthy controls of European ancestry. Replication in other
patient collections was hampered by the lack of a method to obtain the
genotypes without actually performing the laboratory tests. Therefore,
we aimed to develop an imputation methodology for this microsatellite
using the genotypes of SNPs in linkage disequilibrium and to apply it for
validation.
Methods: In our previous study of the MIF microsatellite, we had
included 1090 samples that were also in the arcOGENGWAS. Genotypes
of the 130 SNPs in the linkage disequilibrium region surrounding the
microsatellite in these samples were used as source of haplotype
information. Imputation was done with Impute2 with modiﬁcations
allowing estimation of the probabilities for the number of copies of each
microsatellite allele and their posterior combination. Performance of
this procedure was evaluated in 10 replicates of training, with 90 % of
the samples, and testing of accuracy in the remaining 10 % of the
samples with known microsatellite genotypes. Once concordance of
imputed genotypes with tested genotypes was established, the
approach was applied for the imputation of the MIF microsatellite in
5667 population controls from Wellcome Trust Case-Control Con-
sortium (WTCCC) and in 2466 hip OA cases from arcOGEN (all of them
of European UK ancestry). In addition, we have validated the functional
effect of the MIF microsatellite on the plasma levels of MIF in 361
healthy control samples by ELISA (R&D Systems) from subjects that
were either homozygous for the 5 repeat or the 6 repeat alleles. MIF
microsatellite allele frequencies were compared with POWERMARKER
and differences in plasma levels of MIF were analyzed with ANOVA
using Statistica 7.0 (StatSoft).
Results: There was a microsatellite allele with frequency lower than 1%
that was not included in the imputation. The genotypes of the other
three alleles were imputedwith sufﬁcient accuracy (91.6 %) and call rate
in the reference samples (98.8). However, other microsatellites showed
that the procedure will require further reﬁnements to attain this per-
formance for microsatellites with more alleles. Application of this
procedure to theWTCCC and arcOGEN samples produced genotypes for
99.0 % of the samples. Comparison of the allelic frequencies showedsigniﬁcant differences between hip OA and controls in women (Table 1)
following the same pattern found in our previous study, with the ﬁve
repeats allele less frequent in the patients than in the controls (OR ¼
0.88, [95% CI] 0.79 to 0.98, P ¼ 0.018). However, no difference was
appreciated in men or between control women andmen as it was in our
previous study. This contrast between studies could be attributed to the
use of OA-free controls in the previous study and population controls
here.
Analysis of MIF in plasma of healthy controls showed higher levels in
the homozygous for the 5 repeat allele (3.6 ng/mL) than for the 6 repeat
allele (2.7 ng/mL; P ¼ 0.00025) following the direction previously
reported by other authors andwithout differences betweenwomen and
men.
Conclusions: A new method to impute genotypes of microsatellites
with three alleles based on SNP genotypes has been developed. It has
shown good call rate and accuracy. This procedure allowed us to vali-
date the association of the MIF microsatellite with hip OA in a large
number of cases and controls. Concordance with our previous study
was obtained in women, but not in men. Higher MIF levels were found
in the subjects with the hip OA protective allele. These results should
contribute to deﬁne the role of MIF, an important cytokine, in the OA
pathology.Health Services Research
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ALTERNATIVE SURVIVAL ANALYSIS METHODS TO ESTIMATE TIME TO
REVISION FOLLOWING HIP AND KNEE ARTHROPLASTY: CAN THE
KAPLAN-MEIER METHOD COMPETE?
S. Lacny y, P.D. Faris z,x, E. Bohm k,¶, L.J. Woodhouse#,yy,
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Purpose: With increased longevity and frequency with which joint
replacements are being performed on younger, more physically active
patients, it has become common for patients to outlive the life of their
prosthesis and require a revision. Measuring the cumulative incidence
of revision (i.e., revision rate) provides a measure of the rate of failure
of joint replacements and can be used to project future demand for
revisions. Due to varying patient follow-up times and censoring, sur-
vival analysis is required to estimate revision rates. The Kaplan-Meier
(KM) method is the most commonly applied survival analysis method.
However, it does not account for the competing risk of death and
consequently overestimates the cumulative incidence of revision. This
is problematic given the high rate of competing risks, especially in
older patients receiving joint replacements. Although alternative
methods that account for competing risks have been developed, they
are rarely used within the arthroplasty literature or among joint
replacement registries. Our objective was to assess alternative meth-
ods for estimating the cumulative incidence of revision through
application to population-based cohorts. We evaluated these methods
